Dmk Pharmaceuticals Corporation
DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
16
11 to 50 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Dmk Pharmaceuticals Corporation
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- JS
James Stumpff
Executive Director of Quality · General Business & Management
EmailPhone - FC
Fiona Carleton
Executive Director · General Business & Management
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Dmk Pharmaceuticals Corporation
2 distinct titles indexed · top 2 shown.
- 1executive director
- 1executive director of quality
Sign up to unlock all 2 contacts at Dmk Pharmaceuticals Corporation
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Dmk Pharmaceuticals Corporation
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.